Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib vs Trastuzumab in HER2+ Breast Cancer
NCT00841828Phase 2Completed
- Sponsor
- GEICAM
- Start
- Feb 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by GEICAM. Started Feb 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00841828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841828.